Cited by 2,144Cancer Cells and MetastasisEffects of Radiation ExposureCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Open access

Barker, Holly E., Paget, James T. E., Khan, Aadil A., Harrington, Kevin J.·2015·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Radiotherapy plays a central part in curing cancer. For decades, most research on improving treatment outcomes has focused on modulating radiation-induced biological effects on cancer cells. Recently, we have better understood that components within the tumour microenvironment have pivotal roles in determining treatment outcomes. In this Review, we describe vascular, stromal and immunological changes that are induced in the tumour microenvironment by irradiation and discuss how these changes may promote radioresistance and tumour recurrence. We also highlight how this knowledge is guiding the development of new treatment paradigms in which biologically targeted agents will be combined with radiotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc3958

Cites

200 of 200 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
Retracted
MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H., & Rao, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020614 · Cited by 110
Retracted
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Flagged first, then by citations

Show all 200 references

Sorted by citations

Items 901–1,000 of 1,005

Improved pharmaceutical research and development with AIE-based nanostructures
Zhang, Y., Wang, Y., Wang, J., & Liang, X. (2018) · Materials Horizons · doi:10.1039/c8mh00648b · Cited by 23
An orthotopic non-small cell lung cancer model for image-guided small animal radiotherapy platforms
Iglesias, V. S., van Hoof, S. J., Vaniqui, A., Schyns, L. E. J. R., Lieuwes, N. G., Yaromina, A., Spiegelberg, L., Groot, A. J., Verhaegen, F., Theys, J., et al. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180476 · Cited by 23
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
Lennon, S., Oweida, A., Milner, D. C., Phan, A. V., Bhatia, S., Court, B. V., Darragh, L. B., Mueller, A. C., Raben, D., Martinez-Torrecuadrada, J. L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2811 · Cited by 22
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study
Toss, M. S., Miligy, I. M., Gorringe, K. L., Al-Kawaz, A., Mittal, K., Aneja, R., Ellis, I. O., Green, A. R., Roxanis, I., & Rakha, E. A. (2019) · Modern Pathology · doi:10.1038/s41379-019-0296-7 · Cited by 24
Mambalgin-2 Inhibits Growth, Migration, and Invasion of Metastatic Melanoma Cells by Targeting the Channels Containing an ASIC1a Subunit Whose Up-Regulation Correlates with Poor Survival Prognosis
Bychkov, M. L., Kirichenko, A. V., Shulepko, M. A., Mikhaylova, I. N., Kirpichnikov, M. P., & Lyukmanova, E. N. (2021) · Biomedicines · doi:10.3390/biomedicines9101324 · Cited by 23
Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases
Zhang, S., Long, F., Lin, H., Wang, X., Jiang, G., & Wang, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105936 · Cited by 23
Fluorinated Hyaluronic Acid Encapsulated Perfluorocarbon Nanoparticles as Tumor-Targeted Oxygen Carriers to Enhance Radiotherapy
Wang, W., Wang, X., Tao, F., Hu, K., Zhang, J., Wu, J., You, L., & Zhao, W. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00432 · Cited by 23
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies
Ali, E., Trailin, A. V., Ambrożkiewicz, F., Liška, V., & Hemminki, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315292 · Cited by 25
“The main challenge to classic radiotherapy is its side effects on the surrounding tissues [65].”
Background
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Klapp, V., Buqué, A., Bloy, N., Sato, A., Yamazaki, T., Zhou, X. K., Formenti, S. C., Galluzzi, L., & Petroni, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03964-4 · Cited by 23
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer
Wang, Y., Meng, L., Meng, S., Huang, L., Luo, S., Wu, X., & Gong, X. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2203332 · Cited by 24
“by cell-intrinsic factors and extracellular microenvironment, particularly the immune microenvironment.(3) PD-1 expressed by immune cells can interact with PD-L1 expressed by tumor cells, which inhibits anti-tumor immunity and contributes to immune evasion.”
Background
Biomimetic Upconversion Nanoplatform Synergizes Photodynamic Therapy and Enhanced Radiotherapy against Tumor Metastasis
Zhou, D., Gao, Y., Yang, Z., Wang, N., Ge, J., Cao, X., Kou, D., Gu, Y., Li, C., Afshari, M. J., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03636 · Cited by 23
AIEgen-based nanotherapeutic strategy for enhanced FLASH irradiation to prevent tumour recurrence and avoid severe side effects
Lyu, M., Zhang, T., Yang, L., Xiang, J., Zhu, D., Xia, L., Guo, B., Xu, Y., Yu, H., & Tang, B. Z. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145179 · Cited by 23
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
Sampath, S., Won, H., Massarelli, E., Li, M., Frankel, P. H., Vora, N. L., Vora, L., Maghami, E. G., & Kortylewski, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24397 · Cited by 23
“Cell death induced by ionizing radiation or certain types of chemotherapy results in release of mediators, such as cytokines, chemokines or damageassociated molecular patterns (DAMPs), which modulate activity of immune cells recruited into the tumor after treatment [8].”
Background
Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data‐independent acquisition (DIA) mass spectrometry
Keam, S. P., Gulati, T., Gamell, C., Caramia, F., Huang, C., Schittenhelm, R. B., Kleifeld, O., Neeson, P. J., Haupt, Y., & Williams, S. (2018) · The Prostate · doi:10.1002/pros.23500 · Cited by 23
“Overall, this is consistent with the known features of new tissue deposition and remodeling as relatively late effects of RT on tumor and supportive tissue.(35)”
Result
DNA Repair Deficient Chinese Hamster Ovary Cells Exhibiting Differential Sensitivity to Charged Particle Radiation under Aerobic and Hypoxic Conditions
Cartwright, I. M., Su, C., Haskins, J. S., Salinas, V. A., Sunada, S., Yu, H., Uesaka, M., Hirakawa, H., Chen, D. J., Fujimori, A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082228 · Cited by 23
A Bioenvironment-Responsive Versatile Nanoplatform Enabling Rapid Clearance and Effective Tumor Homing for Oxygen-Enhanced Radiotherapy
Zhang, Q., Chen, J., Ma, M., Wang, H., & Chen, H. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b02251 · Cited by 23
Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
Tanić, M., Krivokuća, A., Cavic, M. R., Mladenović, J., Karapandžić, V. P., Beck, S., Radulovic, S. S., Šušnjar, S. V., & Jankovic, R. N. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1129-4 · Cited by 23
In situ vaccination caused by diverse irradiation-driven cell death programs
Wang, Y., Li, Y., Yang, Y., Swift, M. L., Zhang, Z., Wu, S., Sun, Y., & Yang, K. (2024) · Theranostics · doi:10.7150/thno.86004 · Cited by 25
“From this perspective, irradiation induces a remodeling of the tumor microenvironment through inflammatory cytokines, vascular changes and immunological components, collectively facilitating systemic anti-tumor responses [180, 181].”
Background
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Yan, S., Gan, Y., Xu, H., & Piao, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1526612 · Cited by 22
“Many experimental studies have shown that hypoxic cells are more resistant to ionizing radiation thannormoxic cells, and therefore hypoxic and necrotic areas of tumors often lead to poor therapeutic outcomes or even treatment failure (Barker et al., 2015).”
Recent Progress in Radiosensitive Nanomaterials for Radiotherapy-Triggered Drug Release
Jiang, R., Fang, Q., Liu, W., Chen, L., & Yang, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c23023 · Cited by 22
Tumor Microenvironment Dynamics of Triple-Negative Breast Cancer Under Radiation Therapy
Niture, S. K., Ghosh, S., Jaboin, J. J., & Seneviratne, D. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062795 · Cited by 28
“As in other TME, RT dose and treatment regimen also can potentiate radiation resistance in the bone niche TME [157], and CAFs, and mesenchymal stem cells, can contribute to radioresistance by producing growth factors and ECM components that protect tumor cells [158].”
The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response
Cohen, G., Chandran, P., Lorsung, R. M., Tomlinson, L. E., Sundby, M., Burks, S. R., & Frank, J. A. (2020) · Cancers · doi:10.3390/cancers12020350 · Cited by 23
“B16 tumors (Figure 1A) showed a significantly decreased expression (p 0.05 one-way analysis of variance (ANOVA)) of IL1α, IL1β, IL6, IL17, macrophage colony stimulating factor (M-CSF), granulocyte CSF (G-CSF), keratinocyte chemoattractant (KC), Eotaxin, tumor necrosis factor α (TNFα), Lipopolysaccharide binding protei…”
BackgroundInfluential
Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions
Donini, M., Buti, S., Massari, F., Mollica, V., Rizzo, A., Montironi, R., Bersanelli, M., & Santoni, M. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1770601 · Cited by 21
“regulatory T cells or interleukin-10 [63,64].”
The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer
Peng, L., Wang, Y., Fei, S., Wei, C., Tong, F., Wu, G., Ma, H., & Dong, X. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-500 · Cited by 22
“TAMs are absorbed into the tumor mass following RT with their main treatment-resistant contribution being characterized by the stimulation of angiogenesis and a release of growth factors (8) which, in turn, promote metastasis and tumor relapse after irradiation.”
Background
Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells
Singh, B., Patwardhan, R. S., Jayakumar, S., Sharma, D., & Sandur, S. K. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.112080 · Cited by 22
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
Strell, C., Tullberg, A. S., Edelmann, R. J., Akslen, L. A., Malmström, P., Fernö, M., Holmberg, E. C., Östman, A., & Karlsson, P. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06136-4 · Cited by 22
PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF‐κB in esophageal squamous cancer
Dai, D., Zhou, H., Yin, L., Ye, F., Yuan, X., You, T., Zhao, X., Long, W., Wang, D., He, X., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13134 · Cited by 22
Biochemical and Cellular Characterization of New Radio-Resistant Cell Lines Reveals a Role of Natural Flavonoids to Bypass Senescence
Russo, M., Spagnuolo, C., Moccia, S., Tedesco, I., Lauria, F., & Russo, G. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010301 · Cited by 21
“As an example, in soft-tissue sarcoma cells that, when irradiated, undergo TIS, the addition of senolytic agents, venetoclax (ABT-199) or navitoclax in combination with IR induced rapid apoptotic cell death [33].”
BackgroundInfluential
A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment
van Luijk, I. F., Smith, S. M., Ojeda, M. C. M., Oei, A. L., Kenter, G. G., & Jordanova, E. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092277 · Cited by 22
“The abovementioned events, can shift the balance toward an immunoreactive, as opposed to an immunosuppressive, microenvironment leading to the recruitment and activation of cytotoxic T cells [19,20].”
Background
Tumor acidity/redox hierarchical-activable nanoparticles for precise combination of X-ray-induced photodynamic therapy and hypoxia-activated chemotherapy
Zhang, B., Xue, R., Lyu, J., Gao, A., & Sun, C. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00303a · Cited by 22
Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
Jailkhani, N., Clauser, K. R., Mak, H. H., Rickelt, S., Tian, C., Whittaker, C. A., Tanabe, K. K., Purdy, S. R., Carr, S. A., & Hynes, R. O. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1532 · Cited by 22
“Indeed, ECM plays a role in drug resistance (17 – 19) and is frequently upregulated in response to chemo and radiotherapy.”
Microalgae-based drug delivery systems in biomedical applications
Huang, H., Lang, Y., Wang, S., & Zhou, M. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.01.002 · Cited by 23
Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
Hillman, G. G., Reich, L. A., Rothstein, S. E., Close, L. A., Fountain, M. D., Hankerd, K., Yunker, C. K., Rakowski, J., Quéméneur, É., & Slos, P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0204-3 · Cited by 22
Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells
Grünow, J., Rong, C., Hischmann, J., Zaoui, K., Flechtenmacher, C., Weber, K., Plinkert, P. K., & Heß, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0496-2 · Cited by 21
“intrinsic and acquired resistance remains a major obstacle and serves as a critical barrier for curative treatment of cancer patients, including HNSCC [15].”
Hypermethylation of miR-205-5p by IR Governs Aggressiveness and Metastasis via Regulating Bcl-w and Src
Kim, E., Choi, J. Y., Hwang, S. J., & Bae, I. H. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.12.013 · Cited by 22
“kr INTRODUCTION Ionizing radiation (IR) is widely used as a therapeutic option for many cancer types, but surviving cancer cells often acquire resistance after radiotherapy.(1) Subsequently, the tumor microenvironment is modified, affecting multi-cellular responses, tissue remodeling, local recurrence, and distant met…”
Background
Effect of resveratrol on the radiosensitivity of 5‐FU in human breast cancer MCF‐7 cells
Aghamiri, S., Jafarpour, A., Zandsalimi, F., Aghemiri, M., & Shoja, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28836 · Cited by 23
“Nowadays, combined treatments using chemical/biological agents and radiotherapy have been engaged to either enhance tumor radiosensitivity or reduce radiation side‐effects.(2,33) Because the irradiation efficient enough to control the tumors far exceeds the tolerance of normal tissues.”
Background
The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models
Aydin, Ö. F., Chandran, P., Lorsung, R. M., Cohen, G., Burks, S. R., & Frank, J. A. (2019) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2019.08.014 · Cited by 22
Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box?
Benna, M., Guy, J., Bosacki, C., Jmour, O., Mrad, M. B., Ogorodniitchouk, O., Soltani, S., Lan, M., Daguenet, É., Méry, B., et al. (2020) · British Journal of Radiology · doi:10.1259/bjr.20190147 · Cited by 22
1α,25(OH)2D3 Radiosensitizes Cancer Cells by Activating the NADPH/ROS Pathway
Ji, M., Nie, J., Nie, X.-F., Hu, W., Pei, H., Wan, J., Wang, A., Zhou, G., Zhang, Z., Chang, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00945 · Cited by 22
Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems
Molinaro, M., Skrodzki, D., & Pan, D. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1984 · Cited by 23
Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy
Zhang, Z., Yu, L., Liu, W., & Huang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.044 · Cited by 21
Bifunctional Metal–Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio‐Immunotherapy
Wang, C., Li, J., Jiang, X., Ma, X., Zhen, W., Tillman, L., Weichselbaum, R. R., & Lin, W. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202417027 · Cited by 24
Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination
Sun, Y., Liu, L., He, H., Cui, G., Zheng, Y., Ye, C., Qu, L., Sun, Y., Ji, J., Lammers, T., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.079 · Cited by 22
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy
Zheng, L., Cai, W., Ke, Y., Hu, X., Yang, C., Zhang, R., Wu, H., Liu, D., Yu, H., & Wu, C. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02138-7 · Cited by 23
“RT can not only mediate the DNA damage in tumor cells but also directly affect the TME in which they are located [8, 12].”
Impact of radiation therapy on the immunological tumor microenvironment
Guilbaud, E., Naulin, F., Meziani, L., Deutsch, É., & Galluzzi, L. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.001 · Cited by 25
Pulsed-Focused Ultrasound Slows B16 Melanoma and 4T1 Breast Tumor Growth through Differential Tumor Microenvironmental Changes
Cohen, G., Chandran, P., Lorsung, R. M., Aydin, Ö. F., Tomlinson, L. E., Rosenblatt, R. B., Burks, S. R., & Frank, J. A. (2021) · Cancers · doi:10.3390/cancers13071546 · Cited by 22
“Hot TIME also express tumor necrosis factor alpha (TNFα), interferon gamma (IFNγ), IFNγ-induced protein10 (IP-10/CXCL10), interleukin (IL) 1α, IL1β, IL2, and IL17, and endothelial CAM [8].”
Background
Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids
Silva, V. L., Ruiz, A., Ali, A., Pereira, S. G. T., Seitsonen, J. J. T., Ruokolainen, J., Furlong, F. M., Coulter, J. A., & Al-Jamal, W. T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121018 · Cited by 21
“Hypoxia is also considered a side effect of some cancer treatments, such as photodynamic therapy, antiangiogenic therapy, radiotherapy, and androgen deprivation therapy [6], [7], contributing to therapy resistance by inducing cell quiescence [8].”
Background
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma
Lombardi, D., Tomasoni, M., Lorini, L., Gurizzan, C., Tomasini, D., Ardighieri, L., Battocchio, S., Bozzola, A. M., Mattavelli, D., Paderno, A., et al. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.105764 · Cited by 21
Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling
Orlova, A., Pavlova, K. G., Kurnikov, A. A., Maslennikova, A., Myagcheva, M., Zakharov, E., Skamnitsky, D. V., Perekatova, V., Khilov, A. V., Kovalchuk, A. V., et al. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100778 · Cited by 21
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.
Dehghankelishadi, P., Maritz, M., Dmochowska, N., Badiee, P., Cheah, E., Kempson, I., Berbeco, R., & Thierry, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.017 · Cited by 18
Hydrogels for Antitumor and Antibacterial Therapy
Fang, X., Wang, C., Zhou, S., Cui, P., Hu, H., Ni, X., Jiang, P., & Wang, J. (2022) · Gels · doi:10.3390/gels8050315 · Cited by 21
“Radiation resistance is one of the reasons for the limited efficacy of RT and is related to the tumor microenvironment, such as rapid value-added and hypoxic environment [40].”
Background
The Detection of DNA Damage Response in MCF7 and MDA-MB-231 Breast Cancer Cell Lines after X-ray Exposure
Mahmoud, A. S., Casciati, A., Bakar, Z. A., Hamzah, H. B., Ahmad, T. A. T., & Noor, M. H. M. (2023) · Genome Integrity · doi:10.14293/genint.14.1.001 · Cited by 21
“[19] The stem cell model of cancer development can explain genetic, functional, and phenotypic differences, such as increased resistance to therapy including radiotherapy.”
Background
Radiotherapy, photodynamic therapy, and cryoablation‐induced abscopal effect: Challenges and future prospects
Mohammad, S. A., Hak, A., Pogu, S. V., & Rengan, A. K. (2023) · Cancer Innovation · doi:10.1002/cai2.53 · Cited by 20
“The immune ‐ suppressive mechanism of tumor cells is depicted in Figures 2 and 3 Other regulatory mechanisms that will retard the T ‐ cell activation include PD1 and PDL1, leading to T ‐ cell exhaustion; CTLA4 and OX 40 act as immune check-points [77].”
Background
Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment
Hang, Y., Liu, Y., Teng, Z., Cao, X., & Zhu, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01841-2 · Cited by 22
“CAFs secreted collagen fibers that increase the viscosity of the ECM and impede immune cell infiltration, which ultimately results in T-cell depletion and tumor immune tolerance [28].”
Background
Gastric Cancer Vascularization and the Contribution of Reactive Oxygen Species
Biagioni, A., Peri, S., Versienti, G., Fiorillo, C., Becatti, M., Magnelli, L., & Papucci, L. (2023) · Biomolecules · doi:10.3390/biom13060886 · Cited by 21
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Fakhri, S., Moradi, S. Z., Faraji, F., Farhadi, T., Hesami, O., Iranpanah, A., Webber, K. J., & Bishayee, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10119-w · Cited by 24
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study
Vokes, E. E., Mornex, F., Sezer, A., Cheng, Y., Fang, J., Baz, D. V., Çil, T., Adjei, A. A., Ahn, M., Barlési, F., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.09.1452 · Cited by 21
CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
Chang, H., Wei, J.-W., Tao, Y., Ding, P., Xia, Y., Gao, Y., & Xiao, W. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2017.538 · Cited by 21
Surgical wound fluids from patients treated with intraoperative radiotherapy induce radiobiological response in breast cancer cells
Piotrowski, I., Kulcenty, K. I., Murawa, D., & Suchorska, W. M. (2018) · Medical Oncology · doi:10.1007/s12032-018-1243-z · Cited by 21
Autologous fat transplantation alters gene expression patterns related to inflammation and hypoxia in the irradiated human breast
Lindegren, A., Schultz, I., Sinha, I., Cheung, L. K., Khan, A., Tekle, M., Wickman, M., & Halle, M. (2019) · British journal of surgery · doi:10.1002/bjs.11072 · Cited by 21
Self-citation
Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
Byrne, N. M., Tambe, P., & Coulter, J. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010053 · Cited by 21
“RT is the treatment of choice for a number of cancer, designed to target and kill tumour cells; however, it triggers a myriad of effects on other components of the TME, including the vasculature, stroma and the immune compartment [5].”
BackgroundInfluential
Stereotactic Body Radiotherapy Immunological Planning—A Review With a Proposed Theoretical Model
Swamy, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.729250 · Cited by 21
Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives
Han, R. Q., Zhu, S., & Lin, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091135 · Cited by 21
“The Hf-based nMOFs and nMOLs are also proven to amplify the RT effect by producing hydroxyl radicals [7,26].”
Background
Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective
Suleiman, H., Emerson, A. J., Wilson, P. M., Mulligan, K., Ladner, R. D., & LaBonte, M. J. (2024) · FEBS Journal · doi:10.1111/febs.17278 · Cited by 23
“Methods include promoting immunogenic cell death (ICD) for T-cell priming [46] via oncolytic viruses [47], radiotherapy [48], chemotherapy [49], and toll-like receptor (TLR) agonists treatments [49], alongside T-cell expansion through cancer vaccines [50].”
Comprehensive review of post-treatment imaging in head and neck cancers: from expected to unexpected and beyond
Chakrabarty, N., Mahajan, A., Agrawal, A., Prabhash, K., & Dcruz, A. K. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae207 · Cited by 20
Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC
de Souza, M. G., de Jesus, S. F., Santos, E. M., Gomes, E. S. B., Filho, A. D. P. S., Santos, E. M. S., da Silveira, L. H., Santos, S. H. S., de Paula, A. M. B., Farias, L. C., et al. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0517-2 · Cited by 20
“There is a healthy relationship between poor prognosis and low oxygenation levels in neoplasias [3, 9].”
Background
DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR
Mouawad, M., Biernaski, H., Brackstone, M., Lock, M. I., Yaremko, B., Shmuilovich, O., Kornecki, A., Nachum, I. B., Muscedere, G., Lynn, K. S., et al. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.12.004 · Cited by 20
Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial
Dietrich, A., Andreeff, M., Koi, L., Bergmann, R., Schubert, M., Schreiner, L., Löck, S., Sihver, W., Freudenberg, R., Hering, S., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.11.013 · Cited by 20
Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments
Shin, S.-W., Yang, K., Lee, M., Moon, J., Son, A.-R., Kim, Y., Choi, S., Kim, D.-H., Choi, C., Lee, N., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052637 · Cited by 20
Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers
Cheng, Y., Li, W., Gui, R., Wang, C., Song, J., Wang, Z., Wang, X., Shen, Y., Wang, Z., & Hao, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.671247 · Cited by 22
“Moreover, the acquired resistance of sensitive tissues to radiotherapy is also common (Barker et al., 2015; Kim et al., 2015).”
Background
Multifunctional biomaterials that modulate oxygen levels in the tumor microenvironment
Hu, J., Guan, Z., & Chen, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.019 · Cited by 20
A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
Ji, H., & Zhou, Z. (2022) · Cancers · doi:10.3390/cancers14143505 · Cited by 20
“HDRT recruits immuno-suppressive cell populations such as Tregs, myeloid-derived suppressor cells (MDSCs), and tumorassociated macrophages (TAMs) [29].”
Background
DNA Repair Inhibitors Potentiate Fractionated Radiotherapy More Than Single-Dose Radiotherapy in Breast Cancer Cells
Wong, W.-K., Liberal, F. D. C. G., & McMahon, S. J. (2022) · Cancers · doi:10.3390/cancers14153794 · Cited by 20
“To address this, further in vivo studies should be performed to account for the tumor microenvironment and its influence on radiosensitivity [36].”
Background
An Overview of Recent Advancements on Manganese-Based Nanostructures and Their Application for ROS-Mediated Tumor Therapy
Chen, M., Dong, C., & Shi, S. (2022) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c00689 · Cited by 20
Elastin-like Recombinamer Hydrogels as Platforms for Breast Cancer Modeling
Blanco‐Fernandez, B., Ibáñez‐Fonseca, A., Orbanić, D., Ximenes-Carballo, C., Pérez‐Amodio, S., Rodríguez‐Cabello, J. C., & Engel, E. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.2c01080 · Cited by 22
Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment
Zhao, F., Huang, W., He, L., Nie, S., Sun, Z., Chen, T., Yin, H., & Zhao, J. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101819 · Cited by 20
Immunogenic radiation therapy for enhanced anti-tumor immunity via core-shell nanocomposite-mediated multiple strategies
Huang, N.-H., Qian, A., Zou, Y., Lin, M., Pan, W., Chen, M., Meng, W., Zhang, W., & Chen, J.-X. (2023) · Theranostics · doi:10.7150/thno.84500 · Cited by 20
“Notably, the higher expression of HIF-1α was observed after treatment with RT, probably because X-ray exacerbate tumor hypoxia [10, 41, 42].”
Background
Ultrasmall iron-doped zinc oxide nanoparticles for ferroptosis assisted sono-chemodynamic cancer therapy
Yu, J., Zhu, F., Yang, Y., Zhang, P., Zheng, Y., Chen, H., & Gao, Y. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113606 · Cited by 20
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues
Khan, A., Paget, J. T.-E. H., McLaughlin, M., Kyula, J., Wilkinson, M., Pencavel, T. D., Mansfield, D., Roulstone, V., Seth, R., Halle, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar2041 · Cited by 20
“Fibrosis in LAEs may represent a compensatory response to tissue hypoxia caused by vascular damage (16).”
BackgroundSelf-citation
Wnt Signaling: Paths for Cancer Progression
Carreira-Barbosa, F., & Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_10 · Cited by 20
Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel
Li, K., Li, M., Luo, Z. Y., Mao, Y., Yu, Y., He, Y., Zhou, J., Fei, Y., Pei, Y., & Cai, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.010 · Cited by 20
Synergy of hypoxia relief and chromatin remodeling to overcome tumor radiation resistance
Zhang, Z., Wang, L., Ding, Y., Wu, J., Hu, Y., & Yuan, A. (2020) · Biomaterials Science · doi:10.1039/d0bm00119h · Cited by 20
Rapamycin Promotes ROS-Mediated Cell Death via Functional Inhibition of xCT Expression in Melanoma Under γ-Irradiation
Woo, Y., Lee, H.-J., Kim, J., Kang, S. G., Moon, S., Han, J. A., Jung, Y. M., & Jung, Y.-J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.665420 · Cited by 21
Non-targeted effects of radiation: a personal perspective on the role of exosomes in an evolving paradigm
Kadhim, M. A., Cagatay, S. T., & Elbakrawy, E. M. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1980630 · Cited by 22
“These are commonly referred to as abscopal effects (Barker et al. 2015).”
Background
Irradiation conditioning of adjuvanted, autologous cancer cell membrane nanoparticle vaccines
Tuo, Z., He, Q., Zhang, Z., Wang, Y., Sun, J., Wei, Q., Hu, Y., Lovell, J. F., Jin, H., & Yang, K. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134437 · Cited by 20
Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma
Miki, S., Imamichi, S., Fujimori, H., Tomiyama, A., Fujimoto, K., Satomi, K., Matsushita, Y., Matsuzaki, S., Takahashi, M., Ishikawa, E., et al. (2018) · Cancer Science · doi:10.1111/cas.13637 · Cited by 20
“It is widely known that abnormal angiogenesis occurs after tumor irradiation and that it may contribute to tumor recurrence.(36,37) Since the suppressive effect of eribulin on vascular remodeling was recently reported,(19,20) we determined whether eribulin administration neutralized the radiation-induced abnormal vasc…”
BackgroundInfluential
Spatially fractionated GRID radiation potentiates immune-mediated tumor control
Bekker, R. A., Obertopp, N., Redler, G., Peñagarícano, J., Caudell, J. J., Yamoah, K., Pilon‐Thomas, S., Moros, E. G., & Enderling, H. (2024) · Radiation Oncology · doi:10.1186/s13014-024-02514-6 · Cited by 19
Systemic tumor regression with synergy therapy: radiotherapy and CAR-T
Ma, X., Zhang, W., Zeng, M., Asavasupreechar, T., Kang, S., Li, Y., & Yu, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02245-3 · Cited by 19
Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment
Sarlak, S., Pagès, G., & Luciano, F. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102939 · Cited by 19
“Endothelial cell death and senescence contribute to long-term vascular dysfunction and release cytokines that trigger anti-tumor responses [30,54,55].”
Influential
Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities
Wang, M., Zhao, Y., Xu, K., Liu, C., Zhong, H., Wu, Y., Zhang, K., & Wei, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617968 · Cited by 23
“CAFs orchestrate this process through chemokine-mediated recruitment and functional reprogramming of these cell populations (75).”
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
Donlon, N. E., Sheppard, A., Davern, M., O’Connell, F., Phelan, J. J., Power, R. F., Nugent, T., Dinneen, K., Aird, J. J., Greene, J. P., et al. (2020) · Cancers · doi:10.3390/cancers12113356 · Cited by 18
“Chemotherapy and radiotherapy can have profound effects on reshaping the tumor microenvironment and immune response to cancer, leading to either an enhancement or suppression of anti-tumor immune responses [21,50], which depend on a myriad of tumor–host interactions.”
Background
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
Alcaraz, J., Ikemori, R., Llorente, A., Díaz‐Valdivia, N., Reguart, N., & Vizoso, M. (2021) · Cancers · doi:10.3390/cancers13153782 · Cited by 21
“Finally, our results support that nintedanib (and possibly other antifibrotic drugs) may be particularly useful in overcoming radiotherapy-induced fibrosis in ADC, which has been pointed to as a major process underling pulmonary toxicity and ultimately resistance to radiotherapy [104].”
Result
A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer
Song, J., Zhang, S., Sun, Y., Gu, J., Ye, Z., Sun, X., & Tang, Q. (2021) · Journal of Oncology · doi:10.1155/2021/4338838 · Cited by 19
“Immune microenvironment has been proved to be closely bound up with the regulation of tumor progression and radioresistance [18, 19].”
Background
In Situ Nanotransformable Hydrogel for Chemo-Photothermal Therapy of Localized Tumors and Targeted Therapy of Highly Metastatic Tumors
Alvi, S. B., Rajalakshmi, P. S., Begum, N., Jogdand, A. B., Veeresh, B., & Rengan, A. K. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c17054 · Cited by 20
Mismatch repair system deficiency is associated with chemoradiotherapy resistance in locally advanced rectal adenocarcinoma patients
Ni, K., Zhan, Y., Liu, Z., Zhao, X., Wang, W. “., Wang, G., Zhang, Z., Li, G., Zhang, X., & Zhang, C. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26771 · Cited by 19
Recent advances in radiosensitivity determinants in melanoma
Krayem, M., Ghanem, G. E., & Gestel, D. V. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000818 · Cited by 18
“Several vascular, stromal and immunological changes that are induced in the tumor microenvironment by irradiation may promote radioresistance and tumor recurrence [35].”
Background
Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions
Yadav, D. K., Pradhan, M., Singh, D., & Singh, M. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_4 · Cited by 20
Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts
Lip, H., Amini, M. A., Zetrini, A., Cai, P., Abbasi, A. Z., Bristow, R. G., Rauth, A. M., & Wu, X. Y. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.02.026 · Cited by 19
A DNA-structured mathematical model of cell-cycle progression in cyclic hypoxia
Celora, G. L., Bader, S. B., Hammond, E. M., Maini, P. K., Pitt‐Francis, J., & Byrne, H. M. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111104 · Cited by 17
Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity
Sun, H., Sun, R., Song, X., Gu, W., & Shao, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03392-w · Cited by 19
“Previous studies have shown that the tumor microenvironment mediates the resistance to radiotherapy [56].”
Background

Authors: Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J.
Affiliations: Institute of Cancer Research (GB)
Corresponding author: Barker, Holly E.
ORCID: Barker, Holly E.
Paget, James T. E.
Khan, Aadil A.
Harrington, Kevin J.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2015-06-24
Volume: 15
Issue: 7
Pages: 409-425
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3958
PMC: PMC4896389
OpenAlex: W1912124796
Cited by: 2,144
References: 200
Citations by year: 2026: 181 · 2025: 215 · 2024: 246 · 2023: 242 · 2022: 249 · 2021: 256 · 2020: 230 · 2019: 175 · 2018: 161 · 2017: 119 · 2016: 63 · 2015: 7
FWCI: 12.40
Type: journal article
Language: en
Update notices: erratum (2015-07-24)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Cancer Research UK (C46 ⁄ A10588, C7224/A13407, A13407, 13407)
National Institute for Health and Care Research (CL-2014-22-003)
Rosetrees Trust
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: tumor microenvironment, radioresistance (biology), radiotherapy, tumor stroma, tumor recurrence, vascular changes, immunological changes, combination therapy, molecularly targeted agents
MeSH terms: Animals, Fibroblasts, Humans, Immune Tolerance, Neoplasm Recurrence, Local, Neoplasms, Radiation Tolerance, Cell Hypoxia, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks